These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 26992738)

  • 1. Prostate Cancer Detection Using Computed Very High b-value Diffusion-weighted Imaging: How High Should We Go?
    Rosenkrantz AB; Parikh N; Kierans AS; Kong MX; Babb JS; Taneja SS; Ream JM
    Acad Radiol; 2016 Jun; 23(6):704-11. PubMed ID: 26992738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffusion-weighted imaging of the prostate: Comparison of b1000 and b2000 image sets for index lesion detection.
    Rosenkrantz AB; Hindman N; Lim RP; Das K; Babb JS; Mussi TC; Taneja SS
    J Magn Reson Imaging; 2013 Sep; 38(3):694-700. PubMed ID: 23371846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computed diffusion-weighted imaging of the prostate at 3 T: impact on image quality and tumour detection.
    Rosenkrantz AB; Chandarana H; Hindman N; Deng FM; Babb JS; Taneja SS; Geppert C
    Eur Radiol; 2013 Nov; 23(11):3170-7. PubMed ID: 23756956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the Diagnostic Performance of Synthetic Versus Acquired High b-Value (1500 s/mm
    Park JH; Yun B; Jang M; Ahn HS; Kim SM; Lee SH; Kang E; Kim EK; Park SY
    J Magn Reson Imaging; 2019 Mar; 49(3):857-863. PubMed ID: 30129695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate cancer: utility of fusion of T2-weighted and high b-value diffusion-weighted images for peripheral zone tumor detection and localization.
    Rosenkrantz AB; Mannelli L; Kong X; Niver BE; Berkman DS; Babb JS; Melamed J; Taneja SS
    J Magn Reson Imaging; 2011 Jul; 34(1):95-100. PubMed ID: 21698707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does normalisation improve the diagnostic performance of apparent diffusion coefficient values for prostate cancer assessment? A blinded independent-observer evaluation.
    Rosenkrantz AB; Khalef V; Xu W; Babb JS; Taneja SS; Doshi AM
    Clin Radiol; 2015 Sep; 70(9):1032-7. PubMed ID: 26126712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced Diffusion-weighted Imaging Modeling for Prostate Cancer Characterization: Correlation with Quantitative Histopathologic Tumor Tissue Composition-A Hypothesis-generating Study.
    Hectors SJ; Semaan S; Song C; Lewis S; Haines GK; Tewari A; Rastinehad AR; Taouli B
    Radiology; 2018 Mar; 286(3):918-928. PubMed ID: 29117481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of diffusion-weighted imaging for the prediction of prostate cancer location at 3T using a phased-array coil: preliminary results.
    Kim CK; Park BK; Lee HM; Kwon GY
    Invest Radiol; 2007 Dec; 42(12):842-7. PubMed ID: 18007156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffusion in prostate cancer detection on a 3T scanner: How many b-values are needed?
    de Perrot T; Scheffler M; Boto J; Delattre BM; Combescure C; Pusztaszeri M; Tille JC; Iselin C; Vallée JP
    J Magn Reson Imaging; 2016 Sep; 44(3):601-9. PubMed ID: 26914964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Diffusion Kurtosis Imaging Versus Standard Diffusion Imaging for Detection and Grading of Peripheral Zone Prostate Cancer.
    Roethke MC; Kuder TA; Kuru TH; Fenchel M; Hadaschik BA; Laun FB; Schlemmer HP; Stieltjes B
    Invest Radiol; 2015 Aug; 50(8):483-9. PubMed ID: 25867657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transition zone prostate cancer: revisiting the role of multiparametric MRI at 3 T.
    Rosenkrantz AB; Kim S; Campbell N; Gaing B; Deng FM; Taneja SS
    AJR Am J Roentgenol; 2015 Mar; 204(3):W266-72. PubMed ID: 25714311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal high b-value for diffusion weighted MRI in diagnosing high risk prostate cancers in the peripheral zone.
    Agarwal HK; Mertan FV; Sankineni S; Bernardo M; Senegas J; Keupp J; Daar D; Merino M; Wood BJ; Pinto PA; Choyke PL; Turkbey B
    J Magn Reson Imaging; 2017 Jan; 45(1):125-131. PubMed ID: 27383502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative diffusion-weighted imaging and dynamic contrast-enhanced characterization of the index lesion with multiparametric MRI in prostate cancer patients.
    Yuan Q; Costa DN; Sénégas J; Xi Y; Wiethoff AJ; Rofsky NM; Roehrborn C; Lenkinski RE; Pedrosa I
    J Magn Reson Imaging; 2017 Mar; 45(3):908-916. PubMed ID: 27442039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate cancer: utility of diffusion-weighted imaging as a marker of side-specific risk of extracapsular extension.
    Rosenkrantz AB; Chandarana H; Gilet A; Deng FM; Babb JS; Melamed J; Taneja SS
    J Magn Reson Imaging; 2013 Aug; 38(2):312-9. PubMed ID: 23238968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffusion-weighted imaging in the assessment of prostate cancer: Comparison of zoomed imaging and conventional technique.
    Brendle C; Martirosian P; Schwenzer NF; Kaufmann S; Kruck S; Kramer U; Notohamiprodjo M; Nikolaou K; Schraml C
    Eur J Radiol; 2016 May; 85(5):893-900. PubMed ID: 27130048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What is the optimal b value in diffusion-weighted MR imaging to depict prostate cancer at 3T?
    Metens T; Miranda D; Absil J; Matos C
    Eur Radiol; 2012 Mar; 22(3):703-9. PubMed ID: 21971824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of prostate cancer with MR spectroscopic imaging and diffusion-weighted imaging at 3 Tesla.
    Mazaheri Y; Shukla-Dave A; Goldman DA; Moskowitz CS; Takeda T; Reuter VE; Akin O; Hricak H
    Magn Reson Imaging; 2019 Jan; 55():93-102. PubMed ID: 30176373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Prostate Imaging Reporting and Data System versions 1 and 2 for the Detection of Peripheral Zone Gleason Score 3 + 4 = 7 Cancers.
    Krishna S; McInnes M; Lim C; Lim R; Hakim SW; Flood TA; Schieda N
    AJR Am J Roentgenol; 2017 Dec; 209(6):W365-W373. PubMed ID: 28981356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the impact of computed high b-value diffusion-weighted imaging on prostate cancer detection.
    Verma S; Sarkar S; Young J; Venkataraman R; Yang X; Bhavsar A; Patil N; Donovan J; Gaitonde K
    Abdom Radiol (NY); 2016 May; 41(5):934-45. PubMed ID: 27193792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic performance of diffusion-weighted imaging for prostate cancer: Peripheral zone versus transition zone.
    Lee H; Hwang SI; Lee HJ; Byun SS; Lee SE; Hong SK
    PLoS One; 2018; 13(6):e0199636. PubMed ID: 29933396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.